Sofosbuvir (Savera) Uses in Pakistan — Hepatitis C Treatment

Sofosbuvir (brand: Savera, manufacturer: Ferozsons) is Pakistan's leading licensed Hepatitis C antiviral. This guide covers all approved uses, combinations, and important precautions.

Compiled by the PakVita Editorial Team · AI-assisted drafting with editorial review · Sourced from DRAP, WHO, BNF · Last updated: 2026-06-17

Uses

Quick Answer

Sofosbuvir (Savera 400mg) is used in Pakistan to treat Chronic Hepatitis C virus (HCV) — all genotypes (1, 2, 3, 4). It is not sufficient alone — it is always given in combination with Ledipasvir, Velpatasvir, or Ribavirin. Take only with a hepatologist's prescription.

Primary Uses at a Glance

Chronic Hepatitis C — Genotype 1 (with Ledipasvir)

Sofosbuvir 400mg + Ledipasvir 90mg (Harvoni) is the most commonly used combination for genotype 1 HCV in Pakistan. An 8-12 week course achieves SVR in 90%+ of patients.

After confirmation by a hepatologist — HCV RNA PCR positive and genotype 1 confirmed.

Chronic Hepatitis C — Genotype 2 (with Ribavirin)

For genotype 2 HCV, Sofosbuvir + Ribavirin combination is used for 12 weeks. There is a risk of anaemia with Ribavirin — CBC monitoring is required.

After genotype 2 confirmation, under hepatologist's instruction.

Chronic Hepatitis C — Genotype 3 (with Velpatasvir or Ribavirin)

For genotype 3, Sofosbuvir + Velpatasvir (Epclusa) is given for 12 weeks or Sofosbuvir + Ribavirin for 24 weeks. Ribavirin may be added in cases with cirrhosis.

After genotype 3 PCR confirmation, specialist supervision is required.

Chronic Hepatitis C — Genotype 4 (with Ledipasvir or Velpatasvir)

Sofosbuvir + Ledipasvir or Sofosbuvir + Velpatasvir are effective for genotype 4. Genotypes 3 and 1 are more common in Pakistan, but genotype 4 has also been reported.

The appropriate combination is decided after specialist testing.

HCV in HIV Co-infected Patients

Sofosbuvir-based therapy may be used in co-infection with HCV and HIV, but drug interactions with HIV antiretrovirals require careful review. Only an ID specialist or hepatologist should prescribe this.

Dual specialist (HIV + hepatology) consultation is required.

Other Uses

HCV with liver cirrhosis — carefully monitored regimen
Pre-liver transplant HCV viral load reduction

Sofosbuvir (Savera) Uses — Hepatitis C Treatment

Sofosbuvir 400mg (Savera) is an NS5B RNA polymerase inhibitor that stops Hepatitis C virus (HCV) replication. In Pakistan, Ferozsons Laboratories manufactures it under licence from Gilead Sciences.

Primary Uses (Mukhya Istemal)

Chronic HCV genotype 1 — with Ledipasvir (Harvoni), 8-12 weeks
Chronic HCV genotype 2 — with Ribavirin, 12 weeks
Chronic HCV genotype 3 — with Velpatasvir (Epclusa) or Ribavirin, 12-24 weeks
Chronic HCV genotype 4 — with Ledipasvir or Velpatasvir
HCV-HIV co-infection — under specialist supervision
Pre-transplant viral load reduction — under specialist care

Who Should Take It (Kin Logon ke Liye)

Confirmed chronic HCV infection (HCV RNA PCR positive)
Under the care of a hepatologist or gastroenterologist
After liver function tests, genotype testing, and CBC

When NOT to Use (Kab Nahi Lena Chahiye)

With amiodarone (heart medicine) — fatal bradycardia risk
Pregnancy or breastfeeding
Without a specialist's prescription
Without screening for Hepatitis B — reactivation risk
With rifampicin or St. John's Wort — Sofosbuvir becomes ineffective

Combination Therapy — Available in Pakistan

Combination	Brand Name	HCV Genotypes
Sofosbuvir + Ledipasvir	Harvoni (Ferozsons)	1, 4, 5, 6
Sofosbuvir + Velpatasvir	Epclusa (Ferozsons)	1, 2, 3, 4 (pan-genotypic)
Sofosbuvir + Ribavirin	Generic	2, 3

Summary

Sofosbuvir (Savera) is Pakistan's flagship Hepatitis C medicine. It is pan-genotypic — it can be used across all HCV genotypes. However, it must always be taken as combination therapy under the supervision of a hepatologist. Taking it alone is insufficient and can lead to viral resistance.

The information in this guide is for educational purposes only. Sofosbuvir is a serious prescription medicine — never take it without a specialist's prescription.

Frequently Asked Questions

Sofosbuvir kis kaam aata hai?

Sofosbuvir (Savera 400mg) is used in Pakistan to treat Chronic Hepatitis C virus (HCV). It is an NS5B polymerase inhibitor — it stops HCV replication. It is always given in combination.

Sofosbuvir HCV ke kaunse genotype mein kaam karta hai?

Sofosbuvir is pan-genotypic — it works across genotypes 1, 2, 3, and 4. The doctor chooses the combination partner based on the genotype.

Sofosbuvir akela le sakte hain ya combination zaroori hai?

Sofosbuvir alone (monotherapy) is never sufficient. It must always be taken with an NS5A inhibitor or Ribavirin — otherwise viral resistance can develop.

Sofosbuvir se Hepatitis C theek hoti hai?

Yes — Sofosbuvir-based combination therapy can cure Hepatitis C. SVR is achieved in 90%+ of patients. However, completing the full course is essential.

Sofosbuvir kitni der mein asar dikhata hai?

HCV RNA levels typically drop dramatically within 4 weeks of treatment. However, treatment must continue for 8-24 weeks. Do not stop on your own — relapse can occur.

Sources

DRAP Registered Products Database — Drug Regulatory Authority of Pakistan
WHO Model List of Essential Medicines, 23rd ed. (2023) — World Health Organization
British National Formulary (BNF) — BMJ Group & Pharmaceutical Press

Medical disclaimer

This page is for educational use only and does not replace professional medical advice. Always confirm diagnosis, dose, and interactions with a qualified doctor or pharmacist before starting or changing any medicine.